type
iii
interferon
interferon
lambda
recent
discov
group
interferon
dumouti
et
al
kotenko
et
al
sheppard
et
al
although
clearli
interferon
ank
et
al
doyl
et
al
zhou
et
al
signal
via
complex
consist
receptor
chain
share
structur
featur
chain
famili
cytokin
gad
et
al
type
iii
interferon
distinguish
highli
tissu
specif
receptor
chain
express
cell
epitheli
origin
yet
clearli
defin
small
subset
haematopoiet
cell
mennechet
uze
mordstein
et
al
pott
et
al
liver
particular
interest
report
human
hepatocyt
express
thu
respond
dickensheet
et
al
wang
et
al
human
possess
four
gene
well
pseudogen
lasfar
et
al
fox
et
al
wherea
gene
describ
kotenko
et
al
sheppard
et
al
gene
describ
recent
gene
inactiv
larg
part
human
popul
frameshift
mutat
prokuninaolsson
et
al
phase
clinic
trial
use
pegyl
hepat
c
viru
hcv
infect
recent
complet
ramo
enter
phase
trial
interest
pharmaceut
rather
specif
express
pattern
receptor
reduc
advers
effect
compar
type
ifn
treatment
respons
current
standard
treatment
hcv
infect
consist
pegyl
combin
ribavirin
rbv
depend
viral
genotyp
genet
patient
rather
unexpectedli
singlenucleotid
polymorph
snp
locat
within
around
gene
discov
power
predictor
treatment
outcom
well
likelihood
spontan
clearanc
viru
ge
et
al
thoma
et
al
extens
studi
genet
region
around
gene
reveal
exist
novel
gene
gene
harbour
dinucleotid
variant
tt
tt
allel
lead
frameshift
thu
inactiv
gene
allel
result
function
gene
prokuninaolsson
et
al
human
tt
allel
strongli
posit
associ
hcv
clearanc
well
posit
treatment
outcom
bibert
et
al
prokuninaolsson
et
al
thu
disrupt
gene
benefici
human
context
hcv
infect
though
reason
remain
unclear
transfect
cell
express
plasmid
encod
induc
phosphoryl
author
unabl
detect
signific
secret
protein
ascrib
weak
signal
peptid
sp
prokuninaolsson
et
al
addit
author
produc
recombin
inact
protein
use
insect
cell
howev
protein
purifi
cell
lysat
media
normal
done
secret
protein
appear
like
protein
properli
fold
lack
secret
togeth
clear
observ
intracellular
protein
led
suggest
could
signal
via
intracellular
receptor
booth
georg
lupberg
et
al
ray
furthermor
sequenc
similar
within
first
last
helic
bind
bind
region
poorli
conserv
thu
author
question
whether
actual
signal
express
purifi
refold
e
coli
show
recombin
protein
activ
signal
via
member
type
iii
interferon
famili
furthermor
show
antivir
activ
human
hepatocyt
hcv
primari
human
airway
epithelia
hae
cell
human
coronaviru
strain
well
novel
coronaviru
merscov
demonstr
get
secret
mammalian
cell
substanti
lower
effici
seen
data
suggest
poor
secret
consequ
weak
sp
might
connect
glycosyl
investig
properti
clone
codonoptimis
cdna
encod
matur
form
human
ntermin
tag
follow
tobacco
etch
viru
tev
proteas
cleavag
site
vector
recombin
form
express
e
coli
purifi
inclus
bodi
denatur
condit
metalion
affin
chromatographi
protein
refold
vitro
purifi
homogen
cation
exchang
chromatographi
figur
follow
sizeexclus
chromatographi
figur
dellgren
et
al
elut
sizeexclus
chromatographi
column
ml
consist
expect
monomer
size
purifi
protein
size
kda
figur
correspond
without
sp
residu
ncbi
access
code
effect
recombin
test
cell
cell
stabli
transfect
luciferas
report
control
promot
uze
monneron
recombin
highli
activ
activ
promot
concentrationdepend
manner
compar
figur
verifi
activ
cell
express
natur
cell
treat
induct
wellknown
interferonstimul
gene
isg
oasl
monitor
qpcr
figur
three
interferon
clearli
induc
three
gene
fact
observ
compar
induct
recombin
thu
highli
activ
interferon
determin
receptor
complex
utilis
use
cell
cell
express
low
level
normal
respond
poorli
type
iii
interferon
meager
et
al
howev
express
assay
introduc
luciferas
report
control
promot
order
measur
interferon
activ
time
introduc
transfect
andor
knock
use
specif
sirna
figur
express
transfect
render
highli
respons
howev
signal
larg
lost
knock
use
sirna
figur
signal
significantli
affect
either
overexpress
knockdown
confirm
result
repeat
experi
block
specif
antibodi
previous
shown
block
signal
relat
sheppard
et
al
antibodi
result
activ
report
gene
signal
sensit
antibodi
wherea
signal
unaffect
result
conclus
demonstr
like
member
type
iii
interferon
famili
signal
via
heterodimer
receptor
complex
consist
sinc
interact
receptor
complex
made
sequenc
align
clustal
w
figur
gener
homolog
model
use
swissmodel
workspac
model
figur
overal
structur
similar
figur
expect
homolog
model
follow
observ
valid
accuraci
model
present
close
proxim
minor
local
rearrang
could
form
disulphid
bridg
figur
furthermor
two
conserv
disulphid
link
expect
exist
connect
case
compat
format
disulphid
link
moreov
superimpos
onto
structur
bound
clearli
show
structur
compat
bind
note
prokuninaolson
et
al
residu
helic
f
bind
well
conserv
wherea
dhelix
expect
bind
quit
differ
figur
yet
data
clearli
show
use
signal
model
suggest
conserv
helic
structur
way
present
conserv
residu
helix
primarili
hydrophob
residu
dock
helix
rest
structur
thu
determin
steric
conform
helix
conserv
like
crucial
activ
receptor
chain
need
engag
simultan
howev
import
rememb
share
chain
capabl
bind
sever
differ
cytokin
chain
thu
promiscu
allow
interact
differ
ligand
logsdon
et
al
evalu
whether
structur
compat
bind
superimpos
structur
onto
structur
complex
pdb
entri
code
figur
show
overal
structur
similar
receptorbound
conform
thu
obviou
reason
would
bind
glycosyl
site
equival
interact
weakli
locat
peripheri
interact
site
away
membran
situat
loop
bhelix
mikni
et
al
believ
posit
offer
suffici
flexibl
allow
simultan
glycosyl
receptor
bind
snp
lead
express
associ
poor
spontan
hcv
clearanc
neg
respons
treatment
decid
test
effect
recombin
hcv
infect
cell
transfect
hcv
genom
encod
luciferas
report
posttransfect
cell
treat
h
interferon
treatment
result
concentrationdepend
declin
hcv
replic
figur
b
cell
slightli
weaker
level
experi
repeat
cell
treat
indic
interferon
h
cell
antivir
activ
three
interferon
level
thu
use
two
differ
liver
cell
line
see
measur
differ
chain
primarili
express
cell
epitheli
origin
thu
mostli
exert
effect
therefor
decid
investig
effect
epitheli
cell
system
studi
use
primari
hae
cultur
system
base
primari
human
bronchial
epitheli
cell
grown
interfac
obtain
fulli
differenti
pseudostratifi
hae
layer
reflect
mani
characterist
conduct
human
airway
presenc
basal
secretori
columnar
ciliat
cell
popul
physic
barrier
mucu
kindler
et
al
hae
repres
entri
port
human
respiratori
viru
infect
especi
well
suit
investig
role
hae
cultur
deriv
three
separ
donor
treat
prior
exposur
human
coronaviru
express
luciferas
upon
replic
plaqueform
unit
pfu
van
den
worm
et
al
seen
figur
treat
hae
cultur
reduc
replic
strongest
interferon
wherea
equal
strong
addit
observ
concentrationdepend
effect
perform
experi
test
effect
novel
highli
pathogen
coronaviru
merscov
pfu
observ
concentrationdepend
effect
investig
effect
look
induct
oasl
qpcr
hae
cell
treat
three
interferon
induc
three
gene
induct
level
wherea
slightli
higher
thu
good
agreement
antivir
activ
measur
induct
isg
hypothesis
prokuninaolson
et
al
poor
secret
due
nonfunct
sp
thu
made
chimaer
protein
sp
vice
versa
cell
transfect
construct
protein
secret
evalu
western
blot
media
cell
figur
myc
flagtag
construct
present
media
regardless
whether
sp
contrari
detect
western
blot
media
regardless
sp
thu
poor
secret
sole
ascrib
sp
case
observ
two
band
transfect
cell
around
kda
respect
figur
left
panel
bottom
band
correspond
expect
size
myc
flag
tag
predict
contain
singl
nlink
glycosyl
site
mark
squar
figur
label
figur
upper
band
could
due
glycosyl
test
treat
cell
lysat
cell
pngase
f
cleav
nlink
glycosyl
asparagin
innermost
nacetylchondrosamin
high
mannos
hybrid
complex
oligosaccharid
seen
right
figur
treatment
pngase
f
result
singl
band
kda
show
get
glycosyl
test
whether
activ
secret
transfect
cell
ad
supernat
transfect
cell
figur
transfect
interferoninduc
luciferas
report
system
without
express
result
clear
signal
depend
upon
figur
order
estim
much
secret
titrat
supernat
cell
figur
observ
substanti
lower
activ
supernat
cell
compar
cell
differ
valu
thu
secret
substanti
lower
level
swap
sp
made
differ
equal
well
produc
sp
case
ad
sp
lead
lower
level
secret
interferon
activ
describ
contain
potenti
nlink
glycosyl
site
observ
fraction
intracellular
protein
size
suggest
posttransl
modif
thu
want
address
glycosyl
state
secret
level
low
detect
use
standard
western
blot
first
refin
detect
media
transfect
cell
use
aceton
precipit
figur
western
blot
reveal
size
consist
glycosyl
result
confirm
pngase
f
treatment
next
made
mutant
glycosyl
asparagin
residu
mutat
aspart
cell
transfect
empti
vector
intracellular
extracellular
fraction
analys
western
blot
figur
give
one
band
western
blot
intracellular
fraction
correspond
unmodifi
neither
detect
extracellular
fraction
standard
western
blot
howev
carri
aceton
precipit
media
western
blot
see
clear
band
show
mutat
impair
secret
also
reflect
activ
perform
figur
activ
supernat
cell
transfect
greatli
decreas
compar
cell
transfect
figur
e
coliproduc
fulli
activ
contain
glycosyl
prerequisit
activ
howev
question
aros
whether
glycosyl
activ
whether
low
level
unglycosyl
protein
undetect
western
blot
even
aceton
precipit
mediat
activ
exclud
nonglycosyl
could
sourc
interferon
activ
incub
media
cell
concanavalin
con
bead
con
lectin
bind
termin
mannos
glucos
found
high
mannos
hybrid
nlink
glycan
media
cell
transfect
empti
vector
incub
con
bead
cell
interferon
activ
input
addit
con
bead
activ
remov
incub
bead
figur
show
glycosyl
sourc
measur
interferon
activ
attempt
elut
bead
use
standard
elut
buffer
without
success
seen
lack
activ
figur
protein
figur
eluat
nevertheless
abl
confirm
bound
con
bead
boil
bead
sd
page
buffer
perform
western
blot
figur
produc
recombin
protein
e
coli
observ
substanti
differ
behaviour
compar
isoform
purif
first
test
activ
standard
report
gene
assay
utilis
luciferas
gene
control
gene
promot
uze
monneron
result
dose
respons
curv
compar
furthermor
test
induct
individu
isg
observ
compar
level
induct
isoform
thu
conclud
equal
strong
induc
isg
base
upon
low
sequenc
similar
isoform
region
known
bind
prokuninaolsson
et
al
understand
question
whether
use
receptor
chain
signal
first
confirm
use
receptor
chain
signal
restor
cell
upon
transfect
next
demonstr
involv
sirna
knockdown
block
chain
specif
antibodi
use
defin
receptor
usag
sheppard
et
al
thu
lead
activ
interferon
respons
mediat
antivir
effect
canon
receptor
complex
compos
howev
result
exclud
possibl
signal
type
cytokin
receptor
would
indic
signal
exist
would
involv
regul
classic
isg
measur
antivir
activ
hcv
merscov
compar
antivir
activ
surpris
antivir
activ
respect
indistinguish
viral
infect
model
test
hcv
test
two
differ
hepat
cell
line
neither
case
observ
differ
likewis
use
primari
hae
cell
infect
either
merscov
observ
differ
remark
sequenc
ident
two
isoform
prokuninaolsson
et
al
preliminari
bioinformat
studi
reveal
protein
sequenc
well
conserv
among
mammal
data
shown
thu
must
evolutionari
pressur
keep
function
protein
throughout
mammalian
evolut
sudden
introduct
frameshift
mutat
human
sinc
inactiv
gene
strongli
correl
increas
likelihood
spontan
clearanc
hcv
well
posit
respons
treatment
type
ifn
appear
product
protein
actual
disadvantag
hcv
infect
furthermor
appear
posit
select
human
frameshift
mutat
abolish
product
prokuninaolsson
et
al
whether
select
sole
driven
hcv
current
known
product
could
even
benefici
context
viral
infect
thu
recent
report
snp
shown
favour
treatment
outcom
well
likelihood
spontan
clearanc
hcv
associ
poor
recoveri
hepat
b
viru
infect
kim
et
al
function
interferon
suddenli
becom
liabil
hcv
infect
paradox
current
unabl
explain
discuss
induct
isg
occur
canon
receptor
complex
exclud
activ
outsid
induct
isg
could
mediat
yet
unidentifi
receptor
howev
data
suggest
highli
activ
hcv
despit
fact
shown
predictor
poor
respons
hcv
current
data
exclud
indirect
genet
effect
thu
firmli
proven
protein
causal
agent
poor
prognosi
hcv
patient
function
gene
furthermor
evid
presenc
protein
hcv
patient
exist
date
howev
one
assum
protein
causal
agent
would
suggest
complic
relationship
hcv
human
somehow
impair
full
immun
respons
toward
hcv
produc
fulli
function
protein
use
studi
hepat
immun
cell
furthermor
import
address
whether
hcv
drive
select
tt
allel
nonfunct
human
introduct
tt
allel
chang
suscept
toward
viral
infect
inabl
protein
properli
secret
cell
previous
report
author
specul
might
due
weak
sp
prokuninaolsson
et
al
produc
chimaer
cdna
swap
sp
observ
retain
within
cell
regardless
sp
use
likewis
secret
matur
protein
significantli
affect
sp
use
immunoprecipit
aceton
precipit
abl
show
get
secret
much
lower
effici
seen
also
reflect
reduc
activ
media
cell
compar
media
cell
test
presenc
intracellular
western
blot
cell
lysat
observ
two
isoform
digest
pngase
f
remov
nlink
glycan
reveal
due
incomplet
glycosyl
use
aceton
precipit
concentr
protein
media
abl
show
secret
protein
appear
contain
nlink
glycosyl
agreement
current
dogma
protein
need
complet
glycosyl
export
extracellular
media
clear
us
cell
sens
differ
protein
glycosyl
like
protein
glycosyl
like
produc
glycosylationdefici
mutant
observ
secret
mutant
greatli
impair
confirm
nlink
glycosyl
need
proper
secret
result
also
suggest
use
differ
pathway
secret
remov
nlink
glycosyl
site
suffici
make
shift
secret
pathway
use
nonglycosyl
question
whether
glycosyl
impair
activ
also
rais
e
coliproduc
protein
fulli
activ
obviou
glycosyl
requir
activ
could
interfer
receptor
bind
structur
model
suggest
sugar
attach
outsid
receptorbind
site
activ
recov
supernat
cell
appear
contain
glycosyl
suggest
sugar
interfer
activ
howev
confirm
result
use
con
bead
deplet
media
glycosyl
led
almost
complet
loss
activ
conclud
secret
cell
glycosyl
activ
poor
process
secret
protein
current
make
stand
comparison
protein
data
suggest
block
secret
take
place
transloc
golgi
sp
appear
effici
cleav
lack
secret
led
sever
news
view
paper
suggest
presenc
intracellular
receptor
data
clearli
demonstr
use
normal
receptor
situat
cellular
membran
although
formal
exclud
presenc
intracellular
receptor
howev
consid
like
activ
interferon
pathway
observ
transfect
cell
express
plasmid
prokuninaolsson
et
al
due
low
level
secret
amino
acid
preced
tag
follow
tev
proteas
cleavag
site
codon
optimis
e
coli
purchas
invitrogen
construct
clone
vector
use
fastdigest
kpni
thermo
scientif
catalogu
number
fastdigest
xhoi
thermo
scientif
catalogu
number
e
coli
cell
transform
plasmid
grown
luria
bertani
medium
contain
ampicillin
antifoam
concentr
sigmaaldrich
catalogu
number
continu
shake
protein
express
induc
ad
mm
incub
anoth
h
refold
purif
perform
previous
describ
dellgren
et
al
vector
kind
gift
professor
sergei
kotenko
umdnjnew
jersey
medic
school
newark
usa
human
gene
includ
spsp
purchas
invitrogen
follow
construct
gener
use
accupol
amplicon
catalogu
number
follow
manufactur
instruct
templat
forward
primer
gcttggtaccatgcggccgagtgtctgg
revers
primer
agttctagatcacttgtcatcgtcatccttgtaatccgatccgaggcaaggccc
templat
forward
primer
gcttggtaccatgaccggggactgc
revers
primer
agttctagatcacttgtcatcgtcatccttgtaatcacttccgacacacaggtccccactggc
templat
forward
primer
gcttggtaccatgaccggggactgcatgccagtgctggtgctgatggccgcagtgctgaccgtgactggagcagccccccggcgctgcctgctctcgc
revers
primer
agttctagatcacttgtcatcgtcatccttgtaatccgatccgaggcaaggccc
templat
forward
primer
gcttggtaccatgcggccgagtgtctgggccgcagtggccgcggggctgtgggtcctgtgcacggtgatcgcagaggttcctgtcgccaggctccgcgggg
revers
primer
agttctagatcacttgtcatcgtcatccttgtaatcacttccgacacacaggtccccactggc
well
templat
forward
primer
gcttggtaccatgcggccgagtgtctgg
revers
primer
agttctagatcacagatcctcctcactaatcagtttctgctccgatccgaggcaaggccc
templat
forward
primer
gcttggtaccatgaccggggactgc
revers
primer
agttctagatcacagatcctcctcactaatcagtttctgctcacttccgacacacaggtccccactggc
templat
forward
primer
gcttggtaccatgaccggggactgcatgccagtgctggtgctgatggccgcagtgctgaccgtgactggagcagccccccggcgctgcctgctctcgc
revers
primer
agttctagatcacagatcctcctcactaatcagtttctgctccgatccgaggcaaggccc
templat
forward
primer
gcttggtaccatgcggccgagtgtctgggccgcagtggccgcggggctgtgggtcctgtgcacggtgatcgcagaggttcctgtcgccaggctccgcgggg
revers
primer
agttctagatcacagatcctcctcactaatcagtttctgctcacttccgacacacaggtccccactggc
follow
pcr
programm
use
min
cycl
min
min
min
min
construct
clone
vector
use
fastdigest
kpn
thermo
scientif
catalogu
number
fastdigest
xbai
thermo
scientif
catalogu
number
follow
manufactur
instruct
mutant
gener
sitedirect
mutagenesi
use
vector
templat
reaction
perform
use
pfuultra
ii
primer
gctgggggcagcgcgactgctccttccgcccc
ggggcggaaggagcagtcgcgctgcccccagc
accord
manufactur
instruct
follow
pcr
programm
use
min
cycl
min
min
min
min
unless
otherwis
state
cell
grown
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
uml
penicillin
streptomycin
furthermor
huhlunet
cell
supplement
mm
lglutamin
kept
blasticidin
select
cell
line
supplement
hypoxanthin
thymidin
aminopterin
cell
maintain
hae
cell
gener
previous
describ
kindler
et
al
maintain
month
activ
test
cell
deriv
cell
line
contain
luciferas
report
gene
control
interferon
induc
promot
furthermor
cell
stabli
transfect
render
respons
uze
monneron
measur
interferon
activ
cell
plate
plate
treat
triplic
h
dilut
concentr
rang
cover
ngml
cell
lyse
luciferas
activ
quantifi
use
dualglo
luciferas
assay
system
promega
cell
seed
densiti
cell
per
well
plate
incub
h
fresh
media
ad
indic
interferon
cell
incub
h
lyse
rna
purifi
use
extract
kit
omega
accord
manufactur
instruct
cdna
synthesi
analysi
realtim
quantit
pcr
perform
previous
describ
melchjorsen
et
al
refer
also
list
primer
sequenc
cross
point
amplif
curv
determin
use
second
deriv
method
roch
lightcycl
softwar
roch
data
obtain
light
cycler
normalis
use
mathemat
model
describ
pfaffl
experi
perform
quadrupl
untreat
control
mean
quadrupl
use
calcul
fold
induct
sampl
transfect
experi
cell
per
well
seed
plate
dmem
supplement
fb
left
rest
h
h
cell
transfect
sirna
control
sirna
ontargetplu
pool
thermo
scientif
use
lipofectamin
invitrogen
eighteen
hour
post
transfect
media
chang
fresh
media
supplement
fb
h
post
transfect
cell
transfect
plasmid
encod
firefli
luciferas
control
promot
jorn
et
al
renilla
luciferas
control
promot
sirna
control
sirna
h
media
chang
fresh
media
supplement
fb
cell
left
rest
next
h
eighteen
hour
post
transfect
cell
induc
ngml
uml
chemicon
h
h
cell
wash
pb
lyse
passiv
lysi
buffer
promega
lysat
spun
rcf
min
clear
lysat
use
measur
luciferas
activ
dualluciferas
report
assay
system
promega
cell
seed
plate
concentr
cell
per
ml
dmem
supplement
fb
h
cell
transfect
use
lipofectamin
invitrogen
plasmid
code
firefli
luciferas
control
promot
renilla
luciferas
control
promot
twenti
hour
post
transfect
cell
incub
h
media
contain
r
system
control
antibodi
concentr
cell
induc
ngml
uml
h
induct
cell
lyse
passiv
lysi
buffer
promega
clear
lysat
use
measur
luciferas
activ
dualluciferas
report
assay
system
promega
protein
run
gel
gel
stain
done
use
coomassi
brilliant
blue
western
blot
perform
use
pvdf
star
transfer
membran
applichem
use
supersign
west
dura
extend
durat
substrat
thermo
scientif
membran
expos
mgsr
plu
medic
film
konica
minolta
develop
agfa
curix
film
processor
antibodi
use
mous
myc
antibodi
mous
hybridoma
mous
monoclon
antibodi
sigmaaldrich
catalogu
number
antibodi
goat
r
system
catalogu
number
rabbit
polyclon
gapdh
antibodi
santa
cruz
biotechnolog
catalogu
number
antimous
igg
horseradish
peroxidaselink
speciesspecif
whole
antibodi
sheep
ge
healthcar
catalogu
number
polyclon
swine
antirabbit
immunoglobulinshrp
dako
cytom
catalogu
number
p
align
human
ncbi
access
code
human
ncbi
access
code
perform
clustal
use
default
set
larkin
et
al
fulllength
protein
includ
sp
use
model
gener
swissmodel
workspac
bordoli
et
al
use
sequenc
without
sp
structur
human
pdb
entri
code
model
structur
superimposit
perform
pymol
delano
human
bronchial
epitheli
cell
isol
patient
year
old
underw
bronchoscopi
andor
surgic
lung
resect
diagnost
pathway
pulmonari
diseas
gave
inform
consent
done
accord
local
regul
kanton
st
gallen
switzerland
part
st
gallen
lung
biopsi
biobank
sglbb
kanton
hospit
st
gallen
receiv
approv
ethic
committe
kanton
st
gallen
eksg
eksg
hae
cultur
prepar
previous
describ
dijkman
et
al
hae
cultur
use
day
post
exposur
apic
surfac
air
infect
studi
ifn
sigma
aldrich
ad
basolater
medium
h
prior
infect
basolater
medium
replac
pfu
appli
apic
h
post
infect
renilla
luciferas
activ
determin
cell
lysat
infect
merscov
infect
perform
previous
describ
kindler
et
al
n
cell
line
gener
n
parent
cell
line
bitzegeio
et
al
lentivir
gene
transfer
previous
describ
gentzsch
et
al
constitut
express
firefli
luciferas
gene
fluc
use
assay
marker
cell
viabil
n
cell
cell
narbu
et
al
electropor
vitrotranscrib
rna
previous
describ
haid
et
al
construct
correspond
fulllength
infecti
hcv
chimaer
clone
pietschmann
et
al
express
renilla
luciferas
report
gene
reiss
et
al
electropor
cell
resuspend
ml
complet
medium
seed
dish
four
hour
post
electropor
cell
medium
replac
serial
dilut
ifn
essex
pharma
dilut
triplic
well
use
cell
lyse
deriv
h
post
electropor
passiv
lysi
buffer
promega
renilla
luciferas
activ
measur
evalu
hcv
replic
vieyr
pietschmann
transfect
experi
cell
seed
plate
cellswel
plate
cellswel
dmem
supplement
fb
left
rest
h
h
cell
transfect
use
lipofectamin
invitrogen
either
plasmid
code
format
cotransfect
plasmid
code
firefli
luciferas
control
promot
renilla
luciferas
control
promot
format
six
hour
post
transfect
cell
transfect
given
fresh
media
dmem
fb
uml
penicillin
streptomycin
twenti
hour
post
transfect
media
cell
transfect
harvest
spun
rcf
min
ad
cell
cotransfect
luciferas
differ
dilut
h
cell
wash
pb
lyse
lysat
centrifug
rcf
min
clear
lysat
use
measur
firefli
activ
dualluciferas
report
assay
system
promega
cell
seed
dish
transfect
empti
vector
h
media
chang
media
without
serum
cell
transfect
use
dna
per
dish
use
polyethylenimin
pei
dna
mix
media
without
antibiot
serum
concentr
ml
pei
mix
media
without
antibiot
serum
concentr
ml
dna
pei
mix
left
min
rt
addit
cell
cell
incub
h
media
isol
centrifug
rpm
min
cell
grown
cm
dish
use
ml
media
transfect
describ
supernat
incub
affin
gel
sigmaaldrich
catalogu
number
h
bead
spun
centrifug
rpm
min
supernat
remov
bead
wash
two
time
ml
pb
contain
triton
bead
incub
elut
buffer
pb
contain
triton
flag
peptid
sigmaaldrich
catalogu
number
min
bead
precipit
centrifug
rpm
min
supernat
isol
analys
western
blot
deglycosyl
perform
use
glycerol
free
pngase
f
new
england
biolab
catalogu
number
deglycosyl
cell
lysat
mix
glycoprotein
denatur
buffer
denatur
heat
min
reaction
buffer
pngase
f
ad
mixtur
incub
h
analys
western
blot
media
mix
ratio
media
cold
aceton
sampl
vortex
incub
min
protein
precipit
centrifug
rpm
min
supernat
decant
protein
pellet
resuspend
pb
ml
glucosefre
dmem
sigma
mock
transfect
cell
incub
min
concanavalin
con
bead
bead
media
ad
column
flow
collect
bead
wash
pb
incub
ml
elut
buffer
glucosefre
dmem
supplement
mm
glucos
min
activ
flow
eluat
investig
cell
cotransfect
plasmid
code
firefli
luciferas
control
promot
renilla
luciferas
control
promot
format
previous
describ
protein
content
evalu
flow
eluat
bead
western
blot
bead
boil
sd
load
buffer
min
load
gel
